Cargando…
Treatment of cognitive impairment in Alzheimer's disease
In Alzheimer's disease, cognition now responds to several drugs. Anticholinesterases target the acetylcholine deficit. In mild-to-moderate Alzheimer's disease, they all provide significant benefit versus placebo on the Alzheimer's Disease Assessment ScheduleCognitive Section (ADAS-Cog...
Autor principal: | Burns, Alistair |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Les Laboratoires Servier
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181714/ https://www.ncbi.nlm.nih.gov/pubmed/22034058 |
Ejemplares similares
-
Pharmacotherapy of mild cognitive impairment
por: Gauthier, Serge
Publicado: (2004) -
A critical review of cholinesterase inhibitors as a treatment modality in Alzheimer's disease
por: S. Schneider, Lon
Publicado: (2000) -
Pharmacological models in Alzheimer's disease research
por: Gilles, Christian, et al.
Publicado: (2000) -
Drug treatment of Parkinson's disease
por: Korczyn, Amos D.
Publicado: (2004) -
Cognitive toxicity of drugs used in the elderly
por: von Moltke, Lisa L., et al.
Publicado: (2001)